The Ministry of Health (MoH), in collaboration with Bayer Pharmaceuticals and the German Development Cooperation (GiZ), has organized a national prostate cancer dialogue under the theme “Bridging the Gap in Prostate Cancer Care.”
The event highlighted the pressing need for enhanced education, awareness, and policy development to address the rise of prostate cancer cases in the country, particularly among men aged 40 and above.
Speaking at the event, Hon. Adelaide Ntim, the deputy minister for Health, emphasized the importance of public education to dispel myths and misconceptions surrounding prostate cancer. She stressed the need for accurate information on the risk factors, symptoms, and the significance of early screening in improving prostate cancer outcomes.
“The lack of awareness is one of the major challenges we face. Many men in Ghana avoid screening due to the fear of stigma, and misconceptions about prostate cancer persist in our communities.”
Hon. Adelaide Ntim, Deputy Minister for Health
Hon. Ntim also praised the collaboration between the Ministry of Health, Bayer Pharmaceuticals, and GiZ in launching the “Piloting Prostate Cancer Intervention” project in Accra. She explained that the initiative is designed to raise awareness, promote early detection, and develop strategic policies aimed at improving prostate cancer care in the country.
Prostate cancer is one of the most prevalent forms of cancer worldwide. In 2022 alone, 1,467,854 new prostate cancer cases were recorded globally, making it the fourth most common cancer.
In Ghana, the disease stands as one of the top two reported cancers affecting men. This statistic is alarming for a country where health infrastructure and awareness programs need significant improvement, particularly in rural areas where healthcare access remains limited.
The event attracted a diverse array of stakeholders, including policymakers, healthcare professionals, development partners, Civil Society Organisations (CSOs), traditional rulers, religious leaders, and the media.
The central theme of the gathering was to address the challenges of prostate cancer care and find ways to reduce the barriers to early detection, diagnosis, and treatment.
NHIS Now Expands to Prostate Cancer
In a notable policy development, Dr. Patrick Kuma Aboagye, Director General of the Ghana Health Service, announced the expansion of the National Health Insurance Scheme (NHIS) to include coverage for prostate cancer treatment.
The NHIS benefit package, which previously did not cover many cancer treatments, now extends to wellness services, childhood cancers, and prostate cancer care.
“This is a major step forward in ensuring that prostate cancer is treated as a national health priority. In addition to the NHIS expansion, we have introduced an annual adult screening program that provides adults in Ghana with the opportunity to get screened during their birth months.
“This initiative will help increase the rate of early detection and, ultimately, improve survival rates.”
Dr. Patrick Kuma Aboagye, Director General of the Ghana Health Service
The inclusion of prostate cancer in the NHIS is expected to ease the financial burden on men diagnosed with the disease, especially in lower-income communities, where the cost of cancer treatment can be prohibitively expensive.
Enhancing Diagnostic Capabilities
Wilhelm Hugo, Cluster Coordinator for Sustainable Economic Development at GiZ, highlighted the need for better diagnostic infrastructure to improve prostate cancer care in Ghana.
He revealed that eight health facilities across the country have been equipped with Prostate-Specific Antigen (PSA) testing devices, which are essential for diagnosing prostate cancer. In addition, lab technicians at these facilities have undergone specialized training to ensure the accuracy and reliability of PSA test results.
“Having the necessary equipment and trained personnel is key to ensuring that prostate cancer is diagnosed early and accurately.
“This will reduce the number of cases that go undiagnosed or are detected at an advanced stage when treatment options are limited.”
Wilhelm Hugo, Cluster Coordinator for Sustainable Economic Development at GiZ
The event also focused on the broader context of Ghana’s efforts to tackle non-communicable diseases (NCDs), including prostate cancer, as part of the country’s commitment to achieving Universal Health Coverage (UHC) by 2030.
Dr. Dirus Osei, technical advisor to the Health Minister, emphasized the importance of addressing prostate cancer as part of Ghana’s NCD strategy.
“Tackling prostate cancer is essential if we are to meet our UHC goals. By addressing the risk factors and improving public health awareness, we can significantly reduce the burden of prostate cancer and improve health outcomes for men across the country.”
Dr. Dirus Osei, technical advisor to the Health Minister
Hon. Osei pointed out that comprehensive data collection and research would be crucial for informed decision-making and effective policy implementation. He called for enhanced data systems that would allow health authorities to track prostate cancer cases and trends, which would, in turn, guide resource allocation and program design.
The event concluded with a call to action to further strengthen public-private partnerships, enhance the healthcare infrastructure, and ensure that prostate cancer care is accessible to all men in Ghana, regardless of their socioeconomic status or geographic location.
READ ALSO: Trump To Return To Butler
